Spring/Summer 2024 Campaign
Spring/Summer 2024 Campaign
The CISSS de l’Outaouais’s establishments urgently require several small pieces of equipment that are essential to the performance of recurring tasks carried out by care professionals
The Gatineau laboratory is currently facing a major problem. Free light chain analysis, which is essential for diagnosing and treating multiple myeloma, is sent to a reference laboratory in Montréal. Unfortunately, this process means it takes a very long time to obtain analysis results, with average wait times of 3 to 4 months. Multiple myeloma is a bone marrow cancer that causes an abnormal proliferation of malignant plasma cells, leading to the formation of multiple bone tumours and systemic illness.
What is free light chain analysis? Free light chain analysis is important for the diagnosis, monitoring and management of multiple myeloma. A significant increase in free light chains may indicate disease progression or response to treatment. Doctors use these tests to assess the burden of the disease, monitor the effectiveness of treatments and adjust the treatment plan accordingly.
To remedy this situation, it is essential to equip the CISSS de l’Outaouais’s laboratories with a free light chain analysis device. This technology will enable analyses to be carried out on site, providing much faster results. Serum free light chain testing is essential for diagnosing and monitoring multiple myeloma, and carrying it out in-house will significantly improve the responsiveness and efficiency of care.
Currently, delays in diagnosis can lead to the development of irreversible kidney damage or pathological fractures in some patients. In addition, costly and potentially toxic treatments could be continued unnecessarily for several months because of delayed results, putting patients at risk and leading to needless financial expenditures for the CISSS de l’Outaouais.
The acquisition of a free light chain analyzer will enable:
– Rapid results for the treatment and follow-up of patients with multiple myeloma.
– Improved patient care during treatment, avoiding potential complications.
– More efficient workflow for clinicians, who will be better equipped to follow up on their patients thanks to timely analysis results.
– Reduced unnecessary follow-up visits for patients and doctors, saving time and resources.
– Fewer disparities in care between Outaouais patients and those in other regions.
– More effective treatment follow-up, thereby preventing serious or even irreversible consequences for patients.
In summary, the acquisition of a free light chain analyzer for CISSS de l’Outaouais laboratories is a crucial step towards improving healthcare in the region, reducing delays and ensuring appropriate and rapid treatment for patients with multiple myeloma. This will have a significant impact on patients’ quality of life and on the efficiency of the Outaouais healthcare system.
Commitment of the Gatineau Health Foundation: $105,500
The CISSS de l’Outaouais’s establishments urgently require several small pieces of equipment that are essential to the performance of recurring tasks carried out by care professionals
Faced with this challenge, the laboratory management team at CISSS de l’Outaouais has devised a pioneering solution: a complete cervical cancer screening system using liquid-based Pap tests (ThinPrep).
To help the technical staff and reduce waiting time for patients, the CISSS de l’Outaouais must upgrade the existing software to add specialized modules for specimen traceability, macroscopy assistance, telepathology and management.
Each year, the Gatineau and Hull hospitals’ laboratories perform more than 70,000 analytical procedures on blood products to determine blood groups, verify the presence of antibodies, ensure pregnancy follow-ups, and more.
The CISSS de l’Outaouais’ establishments are in need of several small pieces of equipment that are essential to the performance of recurring tasks by care professionals.
In tomosynthesis, a mobile X-ray tube is used to take a series of pictures and generate a three-dimensional image of the mammary gland.
Traduction 2 Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Traduction 2 Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
